Unique among biologics, insulin biosimilars should be considered interchangeable, FDA told May 14, 2019 By Mari Serebrov
Silicon Valley startup Medneon begins clinico-genetic registry to better assess breast cancer risks May 14, 2019 By Stacy Lawrence
RSS